Skip to main content
Clinical Trials/NCT06282185
NCT06282185
Withdrawn
N/A

SUPERvised Three-month Exercise Program in MEN With Prostate cAncer Receiving Androgen-deprivaTioN thERapy

Canisius-Wilhelmina Hospital1 site in 1 country20 target enrollmentNovember 1, 2024

Overview

Phase
N/A
Intervention
Not specified
Conditions
Prostatic Neoplasms
Sponsor
Canisius-Wilhelmina Hospital
Enrollment
20
Locations
1
Primary Endpoint
change of quality of life assessed with EPIC26 (0-100 points)
Status
Withdrawn
Last Updated
last month

Overview

Brief Summary

The goal of this single blind placebo-controlled intervention study is to examine the impact of a supervised training program on disease-related quality of life and physical fitness in patient with advanced prostate cancer compared to usual care. The main question[s] it aims to answer are:

  • What is the impact of exercise on quality of life
  • What is the impact of exercise on physical fitness

Participants will have an individual training program with supervised training by physiotherapists.

Researchers will compare with usual care to see if advice about exercise has significant less effect than an supervised training program.

Registry
clinicaltrials.gov
Start Date
November 1, 2024
End Date
September 11, 2025
Last Updated
last month
Study Type
Interventional
Study Design
Parallel
Sex
Male

Investigators

Sponsor
Canisius-Wilhelmina Hospital
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Signed informed consent
  • Age \> 18 years old
  • Able to read and complete questionnaires in Dutch
  • Proven histologically and /or radiologically metastatic prostate cancer (TxNxM1)

Exclusion Criteria

  • Other cancers
  • Clinicians' judgement
  • Age \>80 years old or not able to walk 400m
  • Structural exercise (moderate-intensity exercise more than 150 minutes a week) during the past 3 months
  • Musculoskeletal, cardiovascular, or neurological disorders that could inhibit them from exercising
  • Spinal cord compression, history of pathological fractures

Outcomes

Primary Outcomes

change of quality of life assessed with EPIC26 (0-100 points)

Time Frame: 3 months

To examine the impact of a supervised training program on disease-related quality of life in patient with advanced prostate cancer compared to usual care. The following questionnaire is used: Expanded Prostate Cancer Index Composite (EPIC26). With higher scores representing better disease-related quality of life.

change of quality of life assessed with EORTC QLQ-C30 (0-100 points per scale)

Time Frame: 3 months

To examine the impact of a supervised training program on disease-related quality of life in patient with advanced prostate cancer compared to usual care. The following questionnaires are used: European Organization for Research and Treatment for Cancer Quality of Life Questionnaire (EORTC QLQ-C30). A higher score represents a higher response level. So a higher score for the functional scale represents a higher level of physical functioning but a higher score for the symptoms scale represents a higher level of symptoms.

change of quality of life assessed with EPIC26 (0-100 points)

Time Frame: 6 months

To examine the impact of a supervised training program on disease-related quality of life in patient with advanced prostate cancer compared to usual care. The following questionnaire is used: Expanded Prostate Cancer Index Composite (EPIC26). With higher scores representing better disease-related quality of life.

change of quality of life assessed with EORTC QLQ-C30 (0-100 points per scale)

Time Frame: 6 months

To examine the impact of a supervised training program on disease-related quality of life in patient with advanced prostate cancer compared to usual care. The following questionnaires are used: European Organization for Research and Treatment for Cancer Quality of Life Questionnaire (EORTC QLQ-C30). A higher score represents a higher response level. So a higher score for the functional scale represents a higher level of physical functioning but a higher score for the symptoms scale represents a higher level of symptoms.

Secondary Outcomes

  • change of physical fitness in fat percentage(6 months)
  • change of physical fitness in maximum uptake of oxygen in ml/kg/min(3 months)
  • change of fitness assessed with IPAQ-sh (categories (1-3) and continues (MET-minutes))(6 months)
  • change of physical fitness in maximum uptake of oxygen in ml/kg/min(6 months)
  • change of physical fitness in fat percentage(3 months)
  • change of fitness assessed with IPAQ-sh (categories (1-3) and continues (MET-minutes))(3 months)

Study Sites (1)

Loading locations...

Similar Trials